Azitra, Inc. (NYSEAMERICAN:AZTR – Free Report)’s stock is set to reverse split on the morning of Monday, October 26th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, October 25th.
Azitra Price Performance
NYSEAMERICAN:AZTR opened at $0.71 on Thursday. Azitra has a 1 year low of $0.05 and a 1 year high of $1.09. The stock has a 50-day simple moving average of $0.17 and a 200-day simple moving average of $0.18.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.05). On average, equities analysts expect that Azitra will post -0.20 earnings per share for the current year.
Azitra Company Profile
Azitra, Inc is a clinical-stage biotechnology company focused on developing live biotherapeutic products for dermatological conditions. The company uses microbiome science and genetic engineering to develop beneficial bacteria designed for topical application to the skin.
Azitra’s research programs have focused on conditions including atopic dermatitis, acne vulgaris and other skin disorders associated with impaired barrier function or microbial imbalance. Its pipeline has included engineered strains of skin-associated bacteria intended to deliver therapeutic proteins or other biological effects directly to affected areas.
The company was founded in 2014 and is based in New Haven, Connecticut.
Read More
- Five stocks we like better than Azitra
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
